+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Histology and Cytology IVD Market Update

  • Report

  • May 2022
  • Region: Global
  • Kalorama Information
  • ID: 5598385
This report, Histology and Cytology IVD Market Update, provides competitive analysis of the histology/cytology market from 2021 to 2026. Histology/cytology has been a mainstay of the pathological lab, providing information about cells, tissues and organs. A variety of diseases can be identified with a histopathological examination.  Physicians rely on information from the pathologist as to whether there is cancer present or other disease. The physician bases their treatment and prognosis on the pathological information obtained. Technological advancements have increased the knowledge and understanding of the shape-function relationships within tissues and organs and their relationship to disease.

The industry has forged ahead with new technologies that offer increased accuracy and automated workflow. In the coming years, digital imaging, quantitative microscopy, precision microscopy, artificial intelligence and virtual histology will take the histology/cytology industry to the next level.

As discussed in the report, the histology market is a growing market with much potential. This report only looks at traditional histology.

The histology report is segmented into five areas:

  • Traditional non-PAP Stains
  • PAP
  • In situ Hybridization
  • Immunohistochemistry
  • HPV

The histology report also examines and profiles five key market participants:

  • Agilent
  • Danaher
  • Hologic
  • Illumina
  • Roche

Scope and Methodology

The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews, in-person interviews and email correspondence were the primary methods of gathering information. For the purpose of this study, Kalorama Information conducted interviews with industry officials, consultants, health care providers, and government personnel.  These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report.  Additional interviews were completed with relevant company representatives including marketing directors, division managers, and product representatives.

All market data pertains to the world market at the manufacturers’ level. The market includes manufacturer tests.  The base year for data was 2021. Data are provided for 2021 and 2026 with compound annual growth rates (CAGRs) for 2021 and 2026. Competitive analysis is provided for the top five participants in the market. Regional breakdowns are surveyed for United States, Europe, Asia-Pacific and the Rest of World for 2021.  The forecasted market analysis for 2021-2026 was largely based on demographic trends, new developments, innovative technology and global expansion.

Table of Contents

Chapter 1: Executive Summary
  • Industry at a Glance
  • Scope and Methodology
  • Size and Growth of the Market
    • Figure 1-1: Global Histology IVD Market, 2021-2026 ($millions)
  • Competitive Outlook

Chapter 2: Market Analysis
  • Overview Of Histology/Cytology
  • Histology Market Segments
    • Table 2-1:  Global Histology/Cytology Sales by Type, 2021-2026 ($ millions) (Pap Tests, in situ hybridization, immunohistochemistry, traditional non-Pap stains, HPV, TOTAL)
    • Figure 2-1: Histology/Cytology Diagnostic Market Distribution by Broad Test Category, 2021
  • Market Segment by Test Type
  • Traditional Tissue Stains
    • Table 2-2: Selected Vendors of Traditional Histology Stains
  • PAP Tests
    • Table 2-3: Primary and Secondary Prevention of Cervical Cancer, Screening Responses by Country, 2019 (last updated 2020-02-12)
  • Immunohistochemistry and In-Situ Hybridization
    • Table 2-4: Selected in Situ Hybridization-based Tests
    • Table 2-5: Selected IHC Test Innovations
  • HPV
    • Figure 2-2: HPV Screening Market: HPV DNA and Pap Test Distribution of Sales, 2021
    • Table 2-6: Global HPV Molecular (DNA/RNA) Test Sales Distribution by Region, 2021 (North America, Europe, Asia Pacific, RoW)
    • Table 2-7: Selected HPV Test Innovations
  • Market by Region
    • Table 2-8: Global Histology/Cytology Sales Distribution by Region, 2021 (%) (North America, Europe, Asia Pacific, RoW)
  • Competitive Analysis
    • Table 2-9: Revenues of the Major Histology Companies, 2017-2021 ($ millions, estimated)
    • Table 2-10: 2022 Pathology Launches by Roche
  • The Commercial Outlook for Histology

Chapter 3: Major Market Participants
  • Roche Diagnostic
    • Table 3-1: Roche Diagnostic Corporate Summary
    • Figure 3-1: Roche Diagnostics Revenue by Product Group, Full Year Results 2020, 2021, CHF MN
  • Danaher Corporation
    • Table 3-2: Danaher Corporation Summary
    • Figure 3-2: Danaher Diagnostic Segment Performance, Full Year Results, 2020,2021
  • Agilent
    • Table 3-3: Agilent Corporate Summary
    • Table 3-4: Agilent Revenues 2017-2021 (millions $)
  • Illumina, Inc
    • Table 3-5:  Illumina Corporate Summary
    • Table 3-6: Illumina Diagnostics Revenues 2017-2021 (millions $)
  • Hologic
    • Table 3-7: Hologic Corporate Summary
    • Figure 3-3: Hologic Diagnostic Segment Performance, Full Year Results, FY 2020, FY 2021, $M

Companies Mentioned

  • Agilent
  • Danaher
  • Hologic
  • Illumina
  • Roche